Comments

Inhibitor Therapeutics

Q: What sector and industry does Inhibitor Therapeutics (INTI) operate in?

Inhibitor Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.

INTIOTCQB

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.077000

At close: Nov 26, 11:55 AM EDT

Inhibitor Therapeutics (INTI) Forecast

News Earnings Inhibitor Therapeutics (INTI) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Inhibitor Therapeutics (OTC:INTI) Stock Quotes, Forecast and News Summary

Inhibitor Therapeutics Stock (OTC: INTI) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 40.54K
Day Range	- - -
52 Wk Range	0.03 - 0.14
Market Cap	$13.27M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Recent News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	-
Close	-
Volume / Avg.	0 / 40.54K
Day Range	- - -
52 Wk Range	0.03 - 0.14
Market Cap	$13.27M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Inhibitor Therapeutics (INTI) stock?

You can purchase shares of Inhibitor Therapeutics (OTCQB:INTI) through any online brokerage.

View our list of the best stock brokerages

Who are Inhibitor Therapeutics (INTI) competitors?

There are no as such competitors for Inhibitor Therapeutics.

What is the forecast, or price target, for Inhibitor Therapeutics (INTI) stock?

There is no analysis for Inhibitor Therapeutics to provide a consensus price target.

What is the current price for Inhibitor Therapeutics (INTI)?

The stock price for Inhibitor Therapeutics (OTCQB: INTI) is $0.077 last updated November 26, 2024 at 11:55 AM EST.

Does Inhibitor Therapeutics (INTI) pay a dividend?

There are no upcoming dividends for Inhibitor Therapeutics.

When is Inhibitor Therapeutics (OTCQB:INTI) reporting earnings?

Inhibitor Therapeutics does not have any upcoming earnings scheduled.

Is Inhibitor Therapeutics (INTI) going to split?

There is no upcoming split for Inhibitor Therapeutics.

What sector and industry does Inhibitor Therapeutics (INTI) operate in?

Inhibitor Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.